Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
9	11	Search

2024	Chronotropic and Inotropic Effects of Sudachitin, a Polymethoxyflavone from the Peel of <i>Citrus sudachi</i> on Isolated Rat Atria and Its Underlying Mechanisms Biological and Pharmaceutical Bulletin Kazuo Noguchi, Saki Umeda, Misaki Goma, Chinami Ueda, Sawako Tabira, Koto Furuyama, Mirai Taniguchi, Aino Nagai, Midori Matsushita, Haruna Kanae
2023	Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders—Is There a Breakthrough? Antioxidants Jelica Grujić-Milanović, Jovana Rajković, Sladjan Milanović, Vesna Jaćević, Zoran Miloradović, Lana Nežić, Radmila Novaković
2023	Chinese herbal medicine for the treatment of cardiovascular diseases ─ Targeting cardiac ion channels Pharmacological Research Zhenzhen Yan, Ling Zhong, Wandi Zhu, Sookja Kim Chung, Panpan Hou
2022	Research Progress on Natural Products’ Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels Cardiovascular Therapeutics Jinshan He, Sicong Li, Yumeng Ding, Yujia Tong, Xuebin Li
2021	Mitochondrial Dysfunction Increases Arrhythmic Triggers and Substrates; Potential Anti-arrhythmic Pharmacological Targets Frontiers in Cardiovascular Medicine Khalil Saadeh, Ibrahim Talal Fazmin
2021	St. Thomas and del Nido cardioplegia are superior to Custodiol cardioplegia in a rat model of donor heart Scandinavian Cardiovascular Journal Gulsum Karduz, Muhittin Onur Yaman, Mehmet Altan, Gulderen Sahin, Fevzi Toraman, Ugur Aksu
2019	Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile European Journal of Pharmaceutical Sciences Teófilo Vasconcelos, Francisca Araújo, Carlos Lopes, Ana Loureiro, José das Neves, Sara Marques, Bruno Sarmento
2018	Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation? Naunyn-Schmiedeberg's Archives of Pharmacology Henry Sutanto, Dobromir Dobrev, Jordi Heijman
2017	Apelin protects against myocardial ischemic injury by inhibiting dynamin-related protein 1 Oncotarget Wei Xu, Hongwei Yu, Ruixue Ma, Lina Ma, Qiushuang Liu, Huitong Shan, Chengyu Wu, Rong Zhang, Yuhong Zhou, Hongli Shan
	Additional cited-by details will be shown when available from Crossref